← Back to grants
GrantForecasted — not yet open✓ Small businesses may apply

Extracellular Vesicle Therapeutics for Regenerative Medicine (ExTReMe)

National Institutes of Health

Opportunity #
FOR-TR-27-002
Agency
National Institutes of Health
ALN (CFDA)
93.350
Status
forecasted
Posted
Jun 27, 2025
Funding instrument
Cooperative Agreement
Category
Health
Cost sharing required
No

Who can apply

Contact

Christine Happel, Ph.D. National Center for Advancing Translational Sciences (NCATS) · christine.happel@nih.gov

View full notice on Grants.gov ↗